That's a really silly moral stance to take when you are a producer (and marketer) of opioids which lead to hundreds of over-doses annually.
The difference is one patient wants to end their life willingly to escape pain and suffering, while the other is chasing a high and may/may not have been guided into taking Opioids in the first place.
The difference is one patient wants to end their life willingly to escape pain and suffering, while the other is chasing a high and may/may not have been guided into taking Opioids in the first place.
http://fortune.com/2017/05/15/purdue-johnsonandjohnson-opiod...